US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist
  • 1.9900
  • -0.0700-3.40%
Close Jan 6 16:00 ET
  • 1.9900
  • 0.00000.00%
Post 20:01 ET
4.09MMarket Cap-0.17P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-224.97%-2.89M
51.70%-2.25M
-98.35%-3.12M
-24.42%-9.45M
44.26%-2.32M
-60.47%-889K
-394.70%-4.67M
18.50%-1.57M
-102.56%-7.6M
-246.55%-4.17M
Net income from continuing operations
-701.75%-3.09M
32.74%-2.7M
42.79%-4.35M
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
Operating gains losses
99.30%-18K
-270.00%-255K
-86.79%116K
23.69%-4.26M
---2.71M
---2.57M
--150K
--878K
---5.58M
----
Other non cash items
-98.60%14K
-82.55%349K
-55.30%582K
782.83%4.68M
--377K
--1M
--2M
--1.3M
--530K
----
Change In working capital
67.01%-129K
105.73%162K
-91.14%340K
-171.08%-290K
-364.06%-911K
-571.08%-391K
-639.79%-2.83M
960.22%3.84M
188.50%408K
179.68%345K
-Change in receivables
--0
--0
--0
--0
--13K
--13K
---13K
-114.44%-13K
200.00%90K
--0
-Change in prepaid assets
-19.61%41K
-63.57%47K
19.67%-49K
333.33%70K
58.12%-49K
-46.32%51K
1,512.50%129K
-281.25%-61K
-600.00%-30K
-50.00%-117K
-Change in payables and accrued expense
21.30%-170K
103.91%115K
-90.06%389K
-203.45%-360K
-341.13%-1.11M
-1,700.00%-216K
-654.36%-2.94M
1,258.33%3.91M
192.31%348K
236.28%462K
Cash from discontinued investing activities
Operating cash flow
-224.97%-2.89M
51.70%-2.25M
-98.35%-3.12M
-24.42%-9.45M
44.26%-2.32M
-60.47%-889K
-394.70%-4.67M
18.50%-1.57M
-102.56%-7.6M
-246.55%-4.17M
Investing cash flow
Cash flow from continuing investing activities
0
-3M
0
-1M
0
0
Net intangibles purchase and sale
--0
----
----
---3M
--0
---1M
----
----
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
----
----
---3M
--0
---1M
----
----
--0
--0
Financing cash flow
Cash flow from continuing financing activities
18.37%567K
3.98M
46.11%4.53M
-28.60%7.53M
-62.98%3.95M
502.52%479K
0
3.1M
140.61%10.54M
143.32%10.66M
Net common stock issuance
3.09%567K
--295K
--0
-27.60%7.53M
-62.72%3.87M
--550K
--0
--3.1M
106.05%10.39M
--10.39M
Proceeds from stock option exercised by employees
--0
--4.45M
--4.97M
-99.32%1K
--1K
--0
--0
--0
--148K
----
Net other financing activities
--0
---765K
---442K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
18.37%567K
--3.98M
46.11%4.53M
-28.60%7.53M
-62.98%3.95M
502.52%479K
--0
--3.1M
140.61%10.54M
143.32%10.66M
Net cash flow
Beginning cash position
213.11%4.92M
-61.22%3.19M
-73.42%1.78M
78.26%6.71M
-25.81%161K
76.52%1.57M
349.32%8.24M
78.26%6.71M
20.15%3.76M
-62.91%217K
Current changes in cash
-64.68%-2.32M
125.88%1.73M
-7.66%1.41M
-267.23%-4.93M
-75.01%1.62M
-109.51%-1.41M
-606.79%-6.67M
179.17%1.53M
366.72%2.95M
104.25%6.49M
End cash Position
1,513.04%2.6M
213.11%4.92M
-61.22%3.19M
-73.42%1.78M
-73.42%1.78M
-25.81%161K
76.52%1.57M
349.32%8.24M
78.26%6.71M
78.26%6.71M
Free cash flow
-52.94%-2.89M
66.20%-2.25M
-98.35%-3.12M
-63.92%-12.45M
44.26%-2.32M
-240.97%-1.89M
-606.79%-6.67M
18.50%-1.57M
-102.56%-7.6M
-246.55%-4.17M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -224.97%-2.89M51.70%-2.25M-98.35%-3.12M-24.42%-9.45M44.26%-2.32M-60.47%-889K-394.70%-4.67M18.50%-1.57M-102.56%-7.6M-246.55%-4.17M
Net income from continuing operations -701.75%-3.09M32.74%-2.7M42.79%-4.35M-191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K
Operating gains losses 99.30%-18K-270.00%-255K-86.79%116K23.69%-4.26M---2.71M---2.57M--150K--878K---5.58M----
Other non cash items -98.60%14K-82.55%349K-55.30%582K782.83%4.68M--377K--1M--2M--1.3M--530K----
Change In working capital 67.01%-129K105.73%162K-91.14%340K-171.08%-290K-364.06%-911K-571.08%-391K-639.79%-2.83M960.22%3.84M188.50%408K179.68%345K
-Change in receivables --0--0--0--0--13K--13K---13K-114.44%-13K200.00%90K--0
-Change in prepaid assets -19.61%41K-63.57%47K19.67%-49K333.33%70K58.12%-49K-46.32%51K1,512.50%129K-281.25%-61K-600.00%-30K-50.00%-117K
-Change in payables and accrued expense 21.30%-170K103.91%115K-90.06%389K-203.45%-360K-341.13%-1.11M-1,700.00%-216K-654.36%-2.94M1,258.33%3.91M192.31%348K236.28%462K
Cash from discontinued investing activities
Operating cash flow -224.97%-2.89M51.70%-2.25M-98.35%-3.12M-24.42%-9.45M44.26%-2.32M-60.47%-889K-394.70%-4.67M18.50%-1.57M-102.56%-7.6M-246.55%-4.17M
Investing cash flow
Cash flow from continuing investing activities 0-3M0-1M00
Net intangibles purchase and sale --0-----------3M--0---1M----------0--0
Cash from discontinued investing activities
Investing cash flow --0-----------3M--0---1M----------0--0
Financing cash flow
Cash flow from continuing financing activities 18.37%567K3.98M46.11%4.53M-28.60%7.53M-62.98%3.95M502.52%479K03.1M140.61%10.54M143.32%10.66M
Net common stock issuance 3.09%567K--295K--0-27.60%7.53M-62.72%3.87M--550K--0--3.1M106.05%10.39M--10.39M
Proceeds from stock option exercised by employees --0--4.45M--4.97M-99.32%1K--1K--0--0--0--148K----
Net other financing activities --0---765K---442K----------------------------
Cash from discontinued financing activities
Financing cash flow 18.37%567K--3.98M46.11%4.53M-28.60%7.53M-62.98%3.95M502.52%479K--0--3.1M140.61%10.54M143.32%10.66M
Net cash flow
Beginning cash position 213.11%4.92M-61.22%3.19M-73.42%1.78M78.26%6.71M-25.81%161K76.52%1.57M349.32%8.24M78.26%6.71M20.15%3.76M-62.91%217K
Current changes in cash -64.68%-2.32M125.88%1.73M-7.66%1.41M-267.23%-4.93M-75.01%1.62M-109.51%-1.41M-606.79%-6.67M179.17%1.53M366.72%2.95M104.25%6.49M
End cash Position 1,513.04%2.6M213.11%4.92M-61.22%3.19M-73.42%1.78M-73.42%1.78M-25.81%161K76.52%1.57M349.32%8.24M78.26%6.71M78.26%6.71M
Free cash flow -52.94%-2.89M66.20%-2.25M-98.35%-3.12M-63.92%-12.45M44.26%-2.32M-240.97%-1.89M-606.79%-6.67M18.50%-1.57M-102.56%-7.6M-246.55%-4.17M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.61%
Coinbase
COIN
+6.32%
MARA Holdings
MARA
+4.63%
Meta Platforms
META
+4.23%
NVIDIA
NVDA
+3.43%

Unlock the Full List